ライフサイエンスコーパス: squamous

1 ute incidence rate [IR]), prevalence of anal squamous abnormalities, and human papillomavirus (HPV) 1

2 (with lymphovascular invasion), IA2, and IB1 squamous, adenocarcinoma, or adenosquamous carcinoma bet

3 and 2014, we identified 581 SMNs (excluding squamous and basal cell of skin) in 499 individuals.

4 umor types including immune features in lung squamous and basal-like breast cancers.

5 nvestigated; associations were strongest for squamous and small cell carcinomas and weaker for adenoc

6 ion- and apical junction-related proteins in squamous, and extracellular matrix proteins in sarcomato

7 ypes including melanoma, pancreatic and lung squamous cancers.

8 The role of lncRNA LINC00346 in cutaneous squamous carcinoma (cSCC) was examined.

9 advanced laryngeal (LSCC) and hypopharyngeal squamous carcinoma (HPSCC) remains unclear.

10 Lung squamous carcinoma (LUSC) is a highly metastatic disease

11 ork to data from perturbation experiments in squamous carcinoma cell line A431.

12 Gingival fibroblasts and the oral human squamous carcinoma cell line HSC-2 were exposed to inter

13 ry cytokines in oral fibroblasts, oral human squamous carcinoma cells and macrophages in vitro.

14 equired for Notch-induced differentiation of squamous carcinoma cells and TERT-immortalized keratinoc

15 Here, squamous carcinoma cells were seeded at different starti

16 group (n=1 septic shock, n=1 metastatic skin squamous carcinoma).

17 ssed in additional tumor types, such as lung squamous carcinoma.

18 A subset of ocular invasive conjunctival squamous carcinomas express high levels of PD-L1 and CD8

19 owth factor receptor-dependent head and neck squamous cell cancer (HNSCC) cell lines and a synthetic

20 ce severe acute toxicities for head and neck squamous cell cancer (HNSCC) patients treated with conco

21 egression up to 50% in the treatment of lung squamous cell cancer in mice.

22 ents were significantly higher than those of squamous cell cancer patients.

23 These include 2 with squamous cell cancers, 2 with melanoma, 1 with renal cel

24 y), sebaceous gland carcinoma (35 patients), squamous cell carcinoma (26 patients), Merkel cell carci

25 The majority of patients had squamous cell carcinoma (87.8%).

26 usted OR = 0.86; 95% CI: 0.80-0.92), but not squamous cell carcinoma (adjusted OR = 0.99; 95% CI: 0.9

27 elanoma skin cancer (NMSC) such as cutaneous squamous cell carcinoma (cSCC) is caused by solar ultrav

28 Nonmelanoma skin cancer such as cutaneous squamous cell carcinoma (cSCC) is the most common form o

29 invasion (PNI) and desmoplasia on cutaneous squamous cell carcinoma (CSCC) recurrence and metastasis

30 RNA screen to identify targets for cutaneous squamous cell carcinoma (cSCC) therapy in the ubiquitin/

31 ar composition and architecture of cutaneous squamous cell carcinoma (cSCC), we combined single-cell

32 ansplant recipient with metastatic cutaneous squamous cell carcinoma (CSCC).

33 recurrent and/or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC); mortality rates exceed 7

34 Cutaneous squamous cell carcinoma (cuSCC) is the second most commo

35 y to ultraviolet radiation-induced cutaneous squamous cell carcinoma (cuSCC).

36 Equine penile squamous cell carcinoma (EpSCC) is a relatively common c

37 n a detailed immune cell atlas of esophageal squamous cell carcinoma (ESCC) at single-cell resolution

38 hy as a potential risk factor for esophageal squamous cell carcinoma (ESCC) have been inconsistent.

39 Esophageal squamous cell carcinoma (ESCC) is among the most aggress

40 nd regulatory mechanism of YAP in esophageal squamous cell carcinoma (ESCC) remains unclear.

41 Detection of patients with esophageal squamous cell carcinoma (ESCC) who do not benefit from s

42 A-31 (miR-31) is overexpressed in esophageal squamous cell carcinoma (ESCC), a deadly disease associa

43 the etiology and pathogenesis of esophageal squamous cell carcinoma (ESCC).

44 acterize the oncogenic drivers of esophageal squamous cell carcinoma (ESCC).

45 is linked to an increased risk of esophageal squamous cell carcinoma (ESCC).

46 -like protease/differentially expressed in a squamous cell carcinoma (HAT/DESC) cluster of membrane-a

47 d that cortex genes subdivided Head and Neck Squamous Cell Carcinoma (HNSC) tumors and Pheochromocyto

48 h newly diagnosed, first-time, head and neck squamous cell carcinoma (HNSCC) and at least one clinica

49 Head and neck squamous cell carcinoma (HNSCC) arises through exposure

50 Head and neck squamous cell carcinoma (HNSCC) associated with high-ris

51 n of metastatic lymph nodes in head and neck squamous cell carcinoma (HNSCC) cases.

52 an lung cancer cells and human head and neck squamous cell carcinoma (HNSCC) cell lines (UM-SCC-47 an

53 Interrogation of head and neck squamous cell carcinoma (HNSCC) cell lines and patient t

54 Head and neck squamous cell carcinoma (HNSCC) is a disease of signific

55 Tumor hypoxia in head-and-neck squamous cell carcinoma (HNSCC) leads to an immunosuppre

56 Malignant features of head and neck squamous cell carcinoma (HNSCC) may be derived from the

57 Cells from head and neck squamous cell carcinoma (HNSCC) primary tumors had signi

58 val in patients with recurrent head and neck squamous cell carcinoma (HNSCC) than chest x-ray (CXR) p

59 3), a metastatic biomarker for head and neck squamous cell carcinoma (HNSCC), along with two accompan

60 In head and neck squamous cell carcinoma (HNSCC), cell migration facilita

61 roved for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), its role in the managem

62 of immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC).

63 containing 4 (ZSCAN4) in human head and neck squamous cell carcinoma (HNSCC).

64 s with metastatic or recurrent head and neck squamous cell carcinoma (HNSCC).

65 resistance, and recurrence in head and neck squamous cell carcinoma (HNSCC).

66 and are known collectively as head and neck squamous cell carcinoma (HNSCC).

67 (chemo)radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC).

68 t commonly altered oncogene in head and neck squamous cell carcinoma (HNSCC).

69 ab, is an approved therapy for head and neck squamous cell carcinoma (HNSCC).

70 promises for the treatment of head and neck squamous cell carcinoma (HNSCC).

71 nt escalation in patients with head and neck squamous cell carcinoma (HNSCC).

72 nhibits the activity of CBI in head and neck squamous cell carcinoma (HNSCC).

73 lified and overexpressed in head and neck of squamous cell carcinoma (HNSCC).

74 as a first-line treatment for head and neck squamous cell carcinoma (HNSCC).

75 s with locoregionally advanced head and neck squamous cell carcinoma (HNSCC; stage III-IV according t

76 Mechanisms of lung squamous cell carcinoma (LSCC) development are poorly un

77 Laryngeal squamous cell carcinoma (LSCC) responds to 17beta-estrad

78 lidated in a secondary unrelated set of lung squamous cell carcinoma (LUSC) and was shown to be drive

79 eal adenocarcinoma (EA; n = 855), esophageal squamous cell carcinoma (n = 267), and gastric cancer (c

80 the combined outcome laryngeal or pharyngeal squamous cell carcinoma (n = 39) were decreased after an

81 Invasive squamous cell carcinoma (n = 51, 41%) was the most commo

82 tumor proportion score [TPS] >= 50%) and non-squamous cell carcinoma (non-SCC), the Expert Panel reco

83 pression data from patients with oral cavity squamous cell carcinoma (OCSCC) in order to map metabolo

84 The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has been rapidly increas

85 Oropharyngeal squamous cell carcinoma (OPSCC) incidence is increasing

86 ortant determinant of oral and oropharyngeal squamous cell carcinoma (OPSCC) outcomes, yet most of th

87 apillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC).

88 New therapeutic targets for oral squamous cell carcinoma (OSCC) are urgently needed.

89 voke cancer pain.SIGNIFICANCE STATEMENT Oral squamous cell carcinoma (OSCC) is one of the most painfu

90 Oral squamous cell carcinoma (OSCC) is one of the most painfu

91 Oral squamous cell carcinoma (OSCC) is the most common head a

92 Oral squamous cell carcinoma (OSCC) is the most common malign

93 Oral squamous cell carcinoma (OSCC) is the most common type o

94 ess this gap, we used a murine model of oral squamous cell carcinoma (OSCC) of the tongue to investig

95 Oral cancer, predominantly oral squamous cell carcinoma (OSCC), is the eighth-most commo

96 esis mirrors the heterogeneity of human oral squamous cell carcinoma (OSCC), we have performed genomi

97 egional lymph node metastasis (RLNM) in oral squamous cell carcinoma (OSCC).

98 results and revolutionizes treatment of oral squamous cell carcinoma (OSCC).

99 Penile squamous cell carcinoma (PSCC) accounts for over 95% of

100 The incidence of penile squamous cell carcinoma (PSCC) has increased in develope

101 -value thresholds were chosen from published squamous cell carcinoma (SCC) and basal cell carcinoma (

102 Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are both derived from epid

103 Epidermal squamous cell carcinoma (SCC) is a common and highly inv

104 Squamous cell carcinoma (SCC) is a global public health

105 Cutaneous squamous cell carcinoma (SCC) is one of the most common

106 ctrum of diseases from dysplasia to invasive squamous cell carcinoma (SCC) of the conjunctiva.

107 prone actinic keratoses (AKs) and aggressive squamous cell carcinoma (SCC) subtypes.

108 tematic review describing the burden of anal squamous cell carcinoma (SCC), and its surrogates, in SO

109 f medical comorbidities, lower proportion of squamous cell carcinoma (SCC), and more positive lymph n

110 cal benefits in adenocarcinoma (ADC) but not squamous cell carcinoma (SCC), even though the stroma is

111 agement for head and neck cancers, including squamous cell carcinoma (SCC), involves surgical resecti

112 romosome end fusions that also occur in skin Squamous Cell Carcinoma (SCC)-associated CAFs, in which

113 l cell carcinoma (BCC) or invasive cutaneous squamous cell carcinoma (SCC).

114 tures of both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

115 in adenocarcinoma (ADC, 72.5%) compared with squamous cell carcinoma (SQCC, 54.4%).

116 possible, data were extracted separately for squamous cell carcinoma and adenocarcinoma.

117 gically confirmed locally advanced cutaneous squamous cell carcinoma and an Eastern Cooperative Oncol

118 SVC112 reduces tumor growth in head and neck squamous cell carcinoma and increases the effects of rad

119 single-agent treatment in both head and neck squamous cell carcinoma and non-small cell lung cancer.

120 x surgery may decrease the risk of laryngeal squamous cell carcinoma and possibly also of pharyngeal

121 nsive loss of heterozygosity, including lung squamous cell carcinoma and triple-negative breast cance

122 In addition, knockout of ZDHHC19 in lung squamous cell carcinoma cells significantly blocks STAT3

123 uman papillomavirus-associated oropharyngeal squamous cell carcinoma could maintain historical rates

124 Female patients had higher incidence of squamous cell carcinoma despite lower prevalence of beha

125 from a fatal second aggressive head and neck squamous cell carcinoma diagnosed 15 weeks postinclusion

126 ultiple myeloma, oral cancer, and esophageal squamous cell carcinoma did not survive correction for m

127 is approach to a sample of 525 head and neck squamous cell carcinoma exomes, producing a rank-ordered

128 in patients with locally advanced cutaneous squamous cell carcinoma for whom there was no widely acc

129 te staging of viral-associated oropharyngeal squamous cell carcinoma from tobacco and alcohol use-ass

130 d alpha-ketoglutarate production antagonizes squamous cell carcinoma growth.

131 Patients with locally advanced cutaneous squamous cell carcinoma have poor prognosis with convent

132 Squamous cell carcinoma in situ (SCCIS) is a prevalent p

133 WLHIV) have disproportionately high rates of squamous cell carcinoma of the anus compared with the ge

134 f Gynecology and Obstetrics (FIGO) stage IB3 squamous cell carcinoma of the cervix.

135 atients with biopsy-proven adenocarcinoma or squamous cell carcinoma of the esophagus with an initial

136 al cell carcinoma (RCC), endometrial cancer, squamous cell carcinoma of the head and neck (SCCHN), me

137 To identify genetic variants for risk of squamous cell carcinoma of the head and neck (SCCHN), we

138 Remarkably high risks for second in situ squamous cell carcinoma of the skin were found after Kap

139 Patient 1 was on pembrolizumab for his squamous cell carcinoma of the skin, whereas patient 2 r

140 ere identified for each invasive and in situ squamous cell carcinoma of the skin.

141 ndices of UVB-induced DNA damage and delayed squamous cell carcinoma onset induced by chronic UVB.

142 al rates of lung, cervical and head and neck squamous cell carcinoma patients.

143 dence rates, prognosis of invasive cutaneous squamous cell carcinoma remains poor, mainly due to lack

144 es demonstrate that reduced FEV(1) increases squamous cell carcinoma risk (odds ratio (OR) = 1.51, 95

145 Vmax and EUS for nodal disease was higher in squamous cell carcinoma than adenocarcinoma.

146 ter chemopreventive efficacy for UVB-induced squamous cell carcinoma than melanoma mouse models.

147 rend to higher overall complication rates in squamous cell carcinoma versus adenocarcinoma (65% vs 51

148 d adenocarcinoma (83%); however, the rate of squamous cell carcinoma was significantly higher in fema

149 The risk estimates of laryngeal squamous cell carcinoma were particularly decreased >10

150 35), and a significant difference in ARDS in squamous cell carcinoma with 14% versus 2% in adenocarci

151 prostate, pancreas, lung adenocarcinoma, and squamous cell carcinoma) for the frequency of codon muta

152 ses (including 11,273 adenocarcinomas, 7,426 squamous cell carcinoma, and 2,664 small-cell carcinoma

153 g this pipeline to lung adenocarcinoma, lung squamous cell carcinoma, and glioblastoma, genes highly

154 ith increasing risks of lung adenocarcinoma, squamous cell carcinoma, and small cell carcinoma.

155 In SKH1-E mice prone to squamous cell carcinoma, ASA reduced plasma and skin pro

156 in certain types of cancer cells, including squamous cell carcinoma, brain tumor, and osteosarcoma,

157 In lung adenocarcinoma, but not lung squamous cell carcinoma, geometrical irregularity and co

158 onary infection, as well as autoimmunity and squamous cell carcinoma, in addition to even more broad

159 esponsive skin cancers, invasive and in situ squamous cell carcinoma, Kaposi sarcoma, and Merkel cell

160 space invasion, IA2, or IB1 adenocarcinoma, squamous cell carcinoma, or adenosquamous carcinoma of t

161 In human actinic keratosis, a precursor of squamous cell carcinoma, p16(INK4a)-expressing cells are

162 For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy

163 Subjects with basal or squamous cell carcinoma, scheduled for Mohs surgery, wer

164 ded patients with p16-positive oropharyngeal squamous cell carcinoma, smoking history of 10 pack-year

165 We show here, using a mouse model of squamous cell carcinoma, that TICs play a crucial role i

166 d highly aggressive form of undifferentiated squamous cell carcinoma.

167 rspective in a mouse model of salivary gland squamous cell carcinoma.

168 on appearance and risk factors in predicting squamous cell carcinoma.

169 umor microenvironment (TME) of head and neck squamous cell carcinoma.

170 lls (EpdSCs), which are a cell of origin for squamous cell carcinoma.

171 ectrum of oral epithelial dysplasia and oral squamous cell carcinoma.

172 time after surgery was found for pharyngeal squamous cell carcinoma.

173 ux surgery prevents laryngeal and pharyngeal squamous cell carcinoma.

174 ncrease the risk of laryngeal and pharyngeal squamous cell carcinoma.

175 in patients with locally advanced cutaneous squamous cell carcinoma.

176 tivity in patients with metastatic cutaneous squamous cell carcinoma.

177 associated with esophageal adenocarcinoma or squamous cell carcinoma.

178 have sex with men (MSM) are at risk of anal squamous cell carcinoma.

179 cerous lesion that can progress to cutaneous squamous cell carcinoma.

180 and also the leading cause of mortality - is squamous cell carcinoma.

181 rstanding of carcinogenesis in head and neck squamous cell carcinoma.

182 or for nonmelanoma skin cancer, particularly squamous cell carcinoma.

183 cells and evident in patients with basal or squamous cell carcinoma.

184 ival PL with and without progression to oral squamous cell carcinoma.

185 ll carcinoma and possibly also of pharyngeal squamous cell carcinoma.

186 ant anti-cancer therapy in human oral cavity squamous cell carcinoma.

187 uman papillomavirus-associated oropharyngeal squamous cell carcinoma.

188 ll cell carcinoma, urothelial carcinoma, and squamous cell carcinoma.

189 and metastasis of mouse and human cutaneous squamous cell carcinoma.

190 noma from tobacco and alcohol use-associated squamous cell carcinoma.

191 papillomaviruses (beta-HPVs) cause cutaneous squamous cell carcinomas (cSCCs) in a subset of immunoco

192 as co-factor in the development of cutaneous squamous cell carcinomas (cSCCs), particularly in immuno

193 une microenvironment (TIME) of head and neck squamous cell carcinomas (HNSCC) and other solid maligna

194 n, with disparate incidence of head and neck squamous cell carcinomas (HNSCC), including oral cavity

195 anisms remain undefined in the head and neck squamous cell carcinomas (HNSCCs).

196 r human papillomavirus- driven oropharyngeal squamous cell carcinomas (OpSCC) represent distinct clin

197 HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas (OPSCC) we noticed that, while

198 hageal cancers and were more associated with squamous cell carcinomas (P = 0.04).

199 is development and a key oncogenic driver in squamous cell carcinomas (SCC).

200 Skin squamous cell carcinomas (SCCs) are a major cause of dea

201 Squamous cell carcinomas (SCCs) arising from aerodigesti

202 We report that CAFs from skin squamous cell carcinomas (SCCs) display chromosomal alte

203 Examination of human papillomas and squamous cell carcinomas (SCCs) revealed that TC-PTP exp

204 Two histologic subtypes of squamous cell carcinomas (SCCs) were identified-SCCs wit

205 ut of 147 primary cervical cancers, 113 were squamous cell carcinomas (SCCs), and 34 were adenocarcin

206 -3.86), for basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), respectively.

207 ing head and neck, cervical and oesophageal, squamous cell carcinomas display loss of ZNF185 expressi

208 coexpressing IL23 in the stroma of cervical squamous cell carcinomas in situ.

209 and potentiates the progression of invasive squamous cell carcinomas in vivo.

210 cell carcinomas form 'buds', while invasive squamous cell carcinomas initiate as 'folds'.

211 the HER2 signaling axis to drive aggressive squamous cell carcinomas of the head and neck (HNSCC) an

212 of ocular surface or ocular adnexal invasive squamous cell carcinomas were identified in pathology ca

213 Keratinocyte carcinomas, including basal and squamous cell carcinomas, are the most common human canc

214 fferentiation and is frequently disrupted in squamous cell carcinomas, in which Notch is tumor suppre

215 se phenformin for the treatment of cutaneous squamous cell carcinomas.

216 past history of numerous cutaneous basal and squamous cell carcinomas.

217 r female and male genital and anal) and skin squamous cell CIS; additionally RRs were assessed betwee

218 Notch signaling regulates squamous cell proliferation and differentiation and is f

219 It is called squamous cell prostate carcinoma.

220 to the well-established two-step protocol of squamous cell skin carcinoma, in which tumorigenesis is

221 locoregional residual disease after nCRT for squamous cell- or adenocarcinoma.

222 s on the incidence of cases of invasive anal squamous-cell carcinoma (IASCC) in persons with HIV-1, w

223 ffer from other solid tumors like esophageal squamous-cell carcinoma or glioma.

224 show that conditional activation of Notch in squamous cells activates a context-specific gene express

225 sly described mouse "hillock" cells and with squamous cells expressing SCEL and SPRR1A/B.Conclusions:

226 on in submerged airway RPMI 2650 or NCI-H520 squamous cells increased intracellular calcium levels an

227 and DNA-damage response pathways converge in squamous cells on common genes that promote differentiat

228 Squamous cells with nuclear F-actin staining were associ

229 eads to extrusion of veil cell daughters and squamous cells, suggesting veil cell fate is regulated b

230 -control study of in situ (CIS) and invasive squamous cervical cancer (SCC).

231 uppressor genes Trp53 and Rb1 in the gastric squamous-columnar junction (SCJ) epithelium results in p

232 ratinocyte skin cancer, comprising cutaneous squamous (cSCC) and basal cell carcinoma, is the most co

233 The esophageal squamous-derived cell line Het-1A and a rat esophagogast

234 omatoid and basaloid carcinomas with massive squamous differentiation in the above compound mice.

235 A-485 strongly induced squamous differentiation, cell cycle arrest and apoptosi

236 of luminal/intermediate cells in mice drives squamous differentiation.

237 signaling with other pathways that regulate squamous differentiation.

238 MPORTANCE Papillomaviruses infect stratified squamous epithelia, and the viral life cycle is linked t

239 ppo pathway deregulation is also enriched in squamous epithelial cancers.

240 These findings are key to understanding squamous epithelial homeostasis and carcinogenesis.

241 arrett's sequence, we used normal esophageal squamous epithelium (EPC-1, EPC-2), metaplasia (CP-A) an

242 rus pathology, including acantholysis in the squamous epithelium and ballooning degeneration of and i

243 ulation of FGF signaling achieves stratified squamous epithelium from definitive and anterior foregut

244 At the body surface, skin's stratified squamous epithelium is challenged by environmental extre

245 e for mucosal vaccination, however the thick squamous epithelium limits antigen uptake.

246 ly seen as the condition in which the normal squamous epithelium lining of the esophagus is replaced

247 lines (OE33, OE19) and primary specimens of squamous epithelium, metaplasia and EAC.

248 in development of bladder cancer exhibiting squamous features as well as enhanced sensitivity to a b

249 rexpress interleukin 1 beta in esophagus and squamous forestomach and are used as a model of BE).

250 ase report aims to exhibit a case of corneal squamous hyperplasia diagnosed via anterior HR-OCT, prio

251 re conducted with histologic anal high-grade squamous intraepithelial lesion (A-HSIL) as the dependen

252 Anal squamous intraepithelial lesions (ASIL) or anal intraepi

253 ca, are at high risk for cervical high-grade squamous intraepithelial lesions (HSIL) and cervical can

254 nd serological predictors of anal high-grade squamous intraepithelial lesions (HSIL) in human immunod

255 gy (LAST) in low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL), and the AIN cla

256 Anal high-grade squamous intraepithelial lesions (HSILs) ablation may re

257 Anal high-grade squamous intraepithelial lesions (HSILs) precede anal ca

258 n the natural history of the precursor, anal squamous intraepithelial lesions (SIL), are limited.

259 ory of the precursor to this carcinoma, anal squamous intraepithelial lesions (SILs).

260 logy, the pooled prevalence estimate of anal squamous intraepithelial lesions was 22.4% (95% CI, 17.3

261 7% (95% CI, 2.5%-8.5%; I(2) = 0%) high-grade squamous intraepithelial lesions.

262 , and low-grade (LSIL) and high-grade (HSIL) squamous intraepithelial lesions.

263 nomas undergo trans-differentiation into the squamous lineage during disease progression.

264 ng diseases characterized by cilial loss and squamous metaplasia may alter PAR-2 polarization.

265 nes induced pathology akin to the mucous and squamous metaplasia, neutrophilic inflammation, and fibr

266 dy shows that circRNA, CDR1as, promotes lung squamous migration, metastasis, and Golgi trafficking th

267 hat ZBED2 is preferentially expressed in the squamous molecular subtype of human PDA, in association

268 These cells have squamous morphology, feature p53 and NFkB activation and

269 high stromal expression of Prrx1 display the squamous, most aggressive, subtype of PDAC.

270 tients with HGD or EAC and normal esophageal squamous mucosa (controls).

271 and intestinal features replaces esophageal squamous mucosa damaged by gastroesophageal reflux disea

272 thione S-transferase theta 2 (GSTT2) mRNA in squamous mucosa from African American compared with Euro

273 We investigated whether the esophageal squamous mucosa of African American individuals has feat

274 Ocular surface squamous neoplasia includes a spectrum of diseases from

275 PD-L1 and PD-L2, in invasive ocular surface squamous neoplasia.

276 ly or cytologically confirmed metastatic non-squamous non-small-cell lung cancer without sensitising

277 18 years or older, had stage IV or recurrent squamous non-small-cell lung cancer, had previously been

278 ine therapy for patients with metastatic non-squamous non-small-cell lung cancer.

279 dress an unmet need for better therapies for squamous non-small-cell lung cancer.

280 ddress biomarker-driven therapy questions in squamous non-small-cell lung cancer.

281 status included histology [adenocarcinoma vs squamous: odds ratio (OR) 1.75], tumor stage (T1: refere

282 esence of metaplastic components of spindle, squamous, or sarcomatoid histology.

283 Conditioned media experiments revealed that squamous pancreatic cancer cells secrete factors that re

284 ), tumour (T), hyperplastic epidermis and/or squamous papilloma (Hyp/Pap), poorly-differentiated (PDS

285 epicardial cells to transition into a mature squamous phenotype.

286 ferentiation and suggest that is part of the squamous program.

287 neal epithelium to a keratinized, stratified squamous, psoriasiform-like epidermis was observed.

288 eage restricted stem zone that generates the squamous roof plate by direct transformation and asymmet

289 Replication stress was enriched in the squamous subtype of PC (P < .001) but was not associated

290 he ELF3 locus in LUAD which is absent in the squamous subtype.

291 and loss-of-function approaches to show that squamous-subtype pancreatic tumor models become enriched

292 rotein Nrf2) are prevalent in both adeno and squamous subtypes of non-small cell lung cancer, as well

293 classified according to the Lower Anogenital Squamous Terminology (LAST) in low-grade (LSIL) and high

294 Our results provide insight into the squamous to cuboidal to columnar epithelial transitions

295 nced tissue inflammation as a consequence of squamous trans-differentiation in pancreatic cancer, thu

296 Here, we investigated whether squamous trans-differentiation of human and mouse pancre

297 Squamous transformation is a subsequently identified and

298 s indicate the importance of the cuboidal-to-squamous transition in epicardial maturation, a process

299 las, the expression of dACE2 was enriched in squamous tumors of the respiratory, gastrointestinal and

300 relates with the immune infiltration of lung squamous tumors, while tumors with ALAL-1 amplification